Clinical Research

Funding Opportunities


The NINDS extramural research program funds research at institutions throughout the U.S. and around the world. It supports clinical research through several mechanisms, including unsolicited (investigator-initiated) applications, applications for research grants in response to a published Request for Applications (RFA) or Program Announcement (PA), and proposals for contract initiatives through Request for Proposals (RFP). Applications for clinical trials are accepted only in response to targeted, clinical trial-specific initiatives, including clinical trial network initiatives as well as exploratory and phase III trial programs. Investigators are encouraged to review the application process for requirements related to clinical trials.

The mission of the NINDS Office of Clinical Research is:

  • To develop new scientific initiatives to stimulate translation of ideas from basic animal research to testing the safety and early indications of efficacy through phases I and II clinical trials.
  • To promote epidemiological studies of the natural history and early markers of neurological disorders and stroke, to elucidate the causative path leading to the disorders and to stimulate the search for new treatments and prevention strategies.
  • To provide oversight and serve as a resource to the Institute and to the investigators, to ensure the proper level of patient safety monitoring and to maintain the scientific integrity of clinical trials.
  • To participate in the Institute's efforts to develop evidence-based clinical guidelines for physicians and patients.
  • To provide expertise in statistics and clinical trial design to the Institute and to clinical investigators.
  • To initiate and guide the development of phase III clinical trials to test the safety and efficacy of innovative treatments of neurological disorders and stroke.

Program directors throughout the extramural research program oversee and manage clinical studies and trials. Investigators are encouraged to contact the program director who is responsible for the disease of interest (see Personnel). Investigators are also advised to meet with NINDS staff prior to the submission of an application in order to determine the relevance of the proposed research to the NINDS mission and priorities.

Funding Opportunities

Dissemination and Implementation Research in Health (R01)
Release Date: 2016-05-10, Contact: Peter Gilbert, Sc.M., Robin Conwit, M.D., [ (R01)  PAR-16-238  ]

Dissemination and Implementation Research in Health (R21) 
Release Date: 2016-05-10, Contact: Peter Gilbert, Sc.M., Robin Conwit, M.D., [ (R21)  PAR-16-236  ]

Dissemination and Implementation Research in Health (R03)
Release Date: 2016-05-10, Contact: Peter Gilbert, Sc.M., Robin Conwit, M.D., [ (R03)  PAR-16-237  ]

NeuroNEXT Clinical Trials (U01)
Release Date: 2016-03-28, Contact: Robin Conwit, M.D., [ (U01)  PAR-16-155  ]

See all funding opportunities


Common Data Elements, Data Sharing & Archiving

NIH Data Sharing Policy
NINDS believes data sharing is essential to expedite the translation of research results into knowledge, products and procedures to improve human health.  

NINDS Common Data Elements (CDE) Project 
NINDS expects the clinical research it funds to meet the highest standards of scientific rigor yet appreciates the burden that extensive data collection puts on investigators and study participants. Streamline Your Neuroscience Clinical Research using content standards that enable clinical investigators to systematically collect, analyze, and share data across the research community. NINDS strongly encourages researchers who receive funding from the Institute to ensure their data collection is compatible with these common data elements (CDEs).

Archived Clinical Research Datasets
The data from NINDS-supported clinical trials are an important scientific resource, made available to the wider scientific community, while ensuring that the confidentiality and privacy of study participants are protected.  NINDS requires all investigators seeking access to data from archived NINDS-supported trials to agree to certain terms and conditions. 

NINDS Networks

Neurological Emergencies Treatment Trials Network
  Neurological Emergencies Treatment Trials (NETT) Network External link
  Phase III trials of acute injuries and illnesses affecting the brain, spinal cord and peripheral nervous system. 


NeuroNext logo 
  Early phase clinical trials and biomarker studies preparatory to phase III clinical trials in neurological disorders.


Strokenet logo  Stroke Trials Network (NIH StrokeNet)
Phase III clinical trials as well as early phase trials and biomarker studies preparatory to phase III clinical trials in stroke prevention, treatment and recovery.


Scientific Staff Research Area
Clinton B. Wright, M.D., M.S.
Director, Division of Clinical Research
Robin Conwit, M.D.
Program Director
NETT, Neurologic Intervention Studies, ALS, Myasthenia Gravis, Neuropathy, Emergency Research
Janice Cordell, R.N., MPH
Clinical Research Project Manager
NeuroNEXT, Clinical Trials and Epidemiological Studies, Safety Monitoring
Peter Gilbert, Sc.M.
Clinical Research Project Manager
Design, Monitoring and Analysis of Clinical Trials; Exploratory Clinical Trials; Biostatistics
Adam Hartman, M.D.
Program Director
Child Neurology and Epilepsy
Scott Janis, Ph.D.
Program Director
StrokeNet, NETT, Clinical Trials in Stroke and Traumatic Brain Injury
Codrin Lungu, M.D.
Program Director
Parkinson's disease, dystonia, tremor, myoclonus
Carolina Mendoza-Puccini, M.D.
Scientific Program Specialist
StrokeNet, Clinical Trials, and Data and Safety Monitoring Board Liaison
Claudia Moy, Ph.D., MPH
Program Director
StrokeNet, Epidemiology, Patient-centered outcomes; clinical research in stroke and other cerebrovascular disorders
Sara Rue, MPH
Health Specialist
Joanna Vivalda, R.N., MBA, CCRA
Clinical Research Project Manager

StrokeNET, Traumatic Brain Injury, Safety & Risk Assessment, Data and Safety Monitoring Board Liaison

Salina Waddy, M.D.
Program Director

Stroke, Health Disparities, Minority Health